ARDX DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDX

Rosen Law Firm is alerting investors in Ardelyx, Inc. (NASDAQ: ARDX) about a November 16, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Ardelyx provided false and misleading statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing material facts about payer access barriers, prior authorization requirements, and step edit requirements that hindered patient access and new-patient starts.